Rituximab dans le traitement de syndrome lymphoprolifératif après allogreffe de cellules souches hématopoïétiques
- Other title
- Rituximab in the management of lymphoproliferative disorders after allograft stem cell transplantation (en)
- Author
- SANTUCCI, R1 ; LEVEQUE, D1 ; FOHRER, C2 ; BILGER, K2 ; LIOURE, B2
[1] Pôle de pharmacie pharmacologie des Hôpitaux universitaires de Strasbourg, France
[2] Pôle d'oncologie et d'hématologie des Hôpitaux universitaires de Strasbourg, France - Source
Journal de pharmacie clinique (Paris). = International journal of clinical pharmacy. 2009, Vol 28, Num 3, pp 127-133, 7 p ; ref : 34 ref
- CODEN
- JPCLDE
- ISSN
- 0291-1981
- Scientific domain
- Pharmacology drugs
- Publisher
- John Libbey Eurotext, Montrouge
- Publication country
- France
- Document type
- Article
- Language
- French
- Author keyword
- Etude rétrospective Syndrome lymphoprolifératif rituximab
- Keyword (fr)
- Anticancéreux Association médicamenteuse Cellule hématopoïétique Cellule souche Conduite à tenir Efficacité traitement Evaluation performance Homme Homogreffe Immunodépresseur Immunomodulateur Immunothérapie Revue bibliographique Rituximab Rétrospective Syndrome lymphoprolifératif Traitement Anti-CD20 Antigène CD20 Greffe cellules souches Monothérapie Anticorps monoclonal Hémopathie
- Keyword (en)
- Antineoplastic agent Drug combination Hematopoietic cell Stem cell Clinical management Treatment efficiency Performance evaluation Human Homograft Immunosuppressive agent Immunomodulator Immunotherapy Bibliographic review Rituximab Retrospective Lymphoproliferative syndrome Treatment Stem cell transplantation Monotherapy Monoclonal antibody Hemopathy
- Keyword (es)
- Anticanceroso Asociación medicamentosa Célula hematopoyética Célula primitiva Actitud médica Eficacia tratamiento Evaluación prestación Hombre Homoinjerto Inmunodepresor Inmunomodulador Inmunoterapia Revista bibliográfica Rituximab Retrospectiva Linfoproliferativo síndrome Tratamiento Anticuerpo monoclonal Hemopatía
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21907592
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Journal de pharmacie clinique (Paris)\";s:9:\"\u0000*\u0000stitle\";s:23:\"J. pharm. clin. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"127\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0291-1981\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANTUCCI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LEVEQUE, D\";i:1;s:9:\"FOHRER, C\";i:2;s:9:\"BILGER, K\";i:3;s:9:\"LIOURE, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPCLDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Journal de pharmacie clinique (Paris)\";s:9:\"\u0000*\u0000stitle\";s:23:\"J. pharm. clin. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"127\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0291-1981\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANTUCCI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LEVEQUE, D\";i:1;s:9:\"FOHRER, C\";i:2;s:9:\"BILGER, K\";i:3;s:9:\"LIOURE, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPCLDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Journal de pharmacie clinique (Paris)\";s:9:\"\u0000*\u0000stitle\";s:23:\"J. pharm. clin. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"127\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0291-1981\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANTUCCI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LEVEQUE, D\";i:1;s:9:\"FOHRER, C\";i:2;s:9:\"BILGER, K\";i:3;s:9:\"LIOURE, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPCLDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Journal de pharmacie clinique (Paris)\";s:9:\"\u0000*\u0000stitle\";s:23:\"J. pharm. clin. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"127\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0291-1981\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANTUCCI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LEVEQUE, D\";i:1;s:9:\"FOHRER, C\";i:2;s:9:\"BILGER, K\";i:3;s:9:\"LIOURE, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPCLDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Journal de pharmacie clinique (Paris)\";s:9:\"\u0000*\u0000stitle\";s:23:\"J. pharm. clin. (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"127\";s:8:\"\u0000*\u0000epage\";s:3:\"133\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0291-1981\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANTUCCI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:10:\"LEVEQUE, D\";i:1;s:9:\"FOHRER, C\";i:2;s:9:\"BILGER, K\";i:3;s:9:\"LIOURE, B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPCLDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Rituximab dans le traitement de syndrome lymphoprolif\u00e9ratif apr\u00e8s allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\";s:8:\"\u0000*\u0000place\";s:9:\"Montrouge\";s:6:\"\u0000*\u0000pub\";s:20:\"John Libbey Eurotext\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
